University of Kentucky chemistry professor Allan Butterfield's work in neurochemistry and Alzheimer's research is renowned.

But Butterfield's work goes beyond the lab; his support of undergraduate and graduate research at UK is celebrated throughout campus and the Commonwealth, with every research grant and doctoral diploma awarded.

Butterfield served as UK alumnus Tanea Reed's PhD advisor during graduate school.

"He saw my potential and made me a better graduate student by making me a critical thinker," she said. "Dr. Butterfield was a wonderful mentor who was always very encouraging and supportive.  Even though I have since graduated from UK, Dr. Butterfield still plays a role in my career as a mentor."

In a seemingly perfect blending of talents, Butterfield has been appointed as chair of the Neural Oxidative Metabolism and Death Study Section (NOMD) of the Center for Scientific Review (CSR) of the National Institutes of Public Health (NIH).

The role has responsibilities as tall as Butterfield's new title is long. The CSR is the portal for all NIH grant applications and their review for scientific merit.

"Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals and other significant scientific activities, achievements and honors," said CSR Director Toni Scarpa in a congratulatory letter. "The skill and leadership offered by the chairperson determines to a significant extent the effectiveness and efficiency of the review group."

Butterfield will be contributing to the nation's biomedical research effort with each NOMD decision and award.

"I am humbled and honored by this appointment," said Butterfield, "and I believe this appointment reflects well on our department, the College of Arts and Sciences and UK, as well reflecting the strength UK has in research in Alzheimer’s disease,” he continued.  “I know this will be a daunting task, but I am excited to take it on."

NOMD reviews applications studying the molecular mechanisms of neuronal cell death involving aging, neurodegenerative diseases, programmed cell death, necrosis, autophagy and excitotoxicity; reactive oxygen species and oxidative stress associated with neural injury; and mitochondrial biology of neurons and glia in healthy and diseased states across the life span.

This translates to cutting edge research on Alzheimer’s disease, Parkinson’s, multiple sclerosis, aging, DNA dysfunction, stem cell research, traumatic brain injury, hypoglycemia, neurodegenerative diseases and the like.

"Professor Butterfield's appointment as chair of this study section is quite an honor," said chemistry chair Mark Meier. "The National Institutes of Health clearly recognizes Professor Butterfield's international reputation as a researcher in neurochemistry as well as his leadership skills, and this appointment is an honor for him, for the chemistry department and for the university as a whole." 

The CSR organizes peer review groups that evaluate approximately 70 percent of the research grant applications sent to NIH, according to its website. "Since 1946, our mission has remained clear and timely: to see that NIH grant applications receive fair, independent, expert, and timely reviews -- free from inappropriate influences -- so NIH can fund the most promising research."

Butterfield's term runs from July 1, 2011 to June 30, 2012.

by Erin Holaday Ziegler